http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Clene Reports Third Quarter 2021 Operating and Financial Highlights
-
Clene Reports Third Quarter 2021 Operating and Financial Highlights
-
Clene (CLNN) Phase 2 RESCUE-ALS Clinical Trial Did Not Meet Primary or Secondary Endpoints
-
Clene (CLNN) Reports Phase 2 RESCUE-ALS Trial Did Not Meet Endpoints
-
Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial
-
Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial
-
Clene Announces Initiation of a Second FDA Expanded Access Program with CNM-Au8 for People Living with Amyotrophic Lateral Sclerosis
-
Clene Presents Phase 2 CNM-Au8 CNS Target Engagement Data at the International Parkinson and Movement Disorder Society Virtual Congress 2021
-
Clene Completes Final Patient Visit in Phase 2 RESCUE-ALS Study: Topline Data Readout Expected Q4 2021
-
Clene Nanomedicine to Present at Upcoming Virtual Investor Conferences
-
Clene Enters into Two Leases to Materially Expand Manufacturing Capacity of its Lead Asset CNM-Au8®
-
Clene Reports Second Quarter 2021 Operating and Financial Highlights
-
Clene Nanomedicine Appoints Dr. Vallerie McLaughlin to its Board of Directors
-
Clene Reports Positive Top-line Results from its Phase 2 REPAIR Clinical Trials in Parkinson’s Disease and Multiple Sclerosis
-
Clene to Present at Canaccord Genuity's Annual Growth Conference
